Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

<h4>Objectives</h4>In this six-year follow-up study, we used patient-reported outcome measures (PROMs) to compare values at baseline, at 18 months, and at six-year follow up from the CycloME and the RituxME trials.<h4>Methods</h4>Based on the hypothesis that ME/CFS in a subgroup of patients is a var...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ingrid G Rekeland, Kari Sørland, Lisbeth Lykke Neteland, Alexander Fosså, Kine Alme, Kristin Risa, Olav Dahl, Karl J Tronstad, Olav Mella, Øystein Fluge
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Public Library of Science (PLoS) 2024-01-01
Sarja:	PLoS ONE
Linkit:	https://doi.org/10.1371/journal.pone.0307484
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!